US 10011647
IL-33 antagonists and uses thereof
granted A61KA61K38/00A61K38/17
Quick answer
US patent 10011647 (IL-33 antagonists and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jul 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 36
- CPC classes
- A61K, A61K38/00, A61K38/17, A61K38/20, A61K39/3955